Literature DB >> 33126248

Sample-specific perturbation of gene interactions identifies breast cancer subtypes.

Yuanyuan Chen1, Yu Gu2, Zixi Hu2, Xiao Sun2.   

Abstract

Breast cancer is a highly heterogeneous disease, and there are many forms of categorization for breast cancer based on gene expression profiles. Gene expression profiles are variables and may show differences if measured at different time points or under different conditions. In contrast, biological networks are relatively stable over time and under different conditions. In this study, we used a gene interaction network from a new point of view to explore the subtypes of breast cancer based on individual-specific edge perturbations measured by relative gene expression value. Our study reveals that there are four breast cancer subtypes based on gene interaction perturbations at the individual level. The new network-based subtypes of breast cancer show strong heterogeneity in prognosis, somatic mutations, phenotypic changes and enriched pathways. The network-based subtypes are closely related to the PAM50 subtypes and immunohistochemistry index. This work helps us to better understand the heterogeneity and mechanisms of breast cancer from a network perspective.
© The Author(s) 2020. Published by Oxford University Press.

Entities:  

Keywords:  breast cancer; gene interaction network; individual-specific edge perturbations; network-based subtypes

Year:  2021        PMID: 33126248      PMCID: PMC8293822          DOI: 10.1093/bib/bbaa268

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  35 in total

1.  A global test for groups of genes: testing association with a clinical outcome.

Authors:  Jelle J Goeman; Sara A van de Geer; Floor de Kort; Hans C van Houwelingen
Journal:  Bioinformatics       Date:  2004-01-01       Impact factor: 6.937

2.  Are clusters found in one dataset present in another dataset?

Authors:  Amy V Kapp; Robert Tibshirani
Journal:  Biostatistics       Date:  2006-04-12       Impact factor: 5.899

3.  Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.

Authors:  Antonino B D'Assoro; Alexey Leontovich; Angela Amato; Jennifer R Ayers-Ringler; Cosima Quatraro; Kari Hafner; Robert B Jenkins; Massimo Libra; James Ingle; Franca Stivala; Evanthia Galanis; Jeffrey L Salisbury
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

4.  Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Authors:  T Aas; A L Børresen; S Geisler; B Smith-Sørensen; H Johnsen; J E Varhaug; L A Akslen; P E Lønning
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

5.  Cell-specific network constructed by single-cell RNA sequencing data.

Authors:  Hao Dai; Lin Li; Tao Zeng; Luonan Chen
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

6.  Towards precise classification of cancers based on robust gene functional expression profiles.

Authors:  Zheng Guo; Tianwen Zhang; Xia Li; Qi Wang; Jianzhen Xu; Hui Yu; Jing Zhu; Haiyun Wang; Chenguang Wang; Eric J Topol; Qing Wang; Shaoqi Rao
Journal:  BMC Bioinformatics       Date:  2005-03-17       Impact factor: 3.169

7.  A rank-based algorithm of differential expression analysis for small cell line data with statistical control.

Authors:  Xiangyu Li; Hao Cai; Xianlong Wang; Lu Ao; You Guo; Jun He; Yunyan Gu; Lishuang Qi; Qingzhou Guan; Xu Lin; Zheng Guo
Journal:  Brief Bioinform       Date:  2019-03-22       Impact factor: 11.622

8.  Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.

Authors:  H Joshi; G Bhanot; A-L Børresen-Dale; V Kristensen
Journal:  Br J Cancer       Date:  2012-10-18       Impact factor: 7.640

9.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

10.  Portraying breast cancers with long noncoding RNAs.

Authors:  Olivier Van Grembergen; Martin Bizet; Eric J de Bony; Emilie Calonne; Pascale Putmans; Sylvain Brohée; Catharina Olsen; Mingzhou Guo; Gianluca Bontempi; Christos Sotiriou; Matthieu Defrance; François Fuks
Journal:  Sci Adv       Date:  2016-09-02       Impact factor: 14.136

View more
  6 in total

1.  Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes.

Authors:  Ran Wei; Huihui Zhang; Jianzhong Cao; Dailei Qin; Shengping Li; Wuguo Deng
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Construction and analysis of sample-specific driver modules for breast cancer.

Authors:  Yuanyuan Chen; Haitao Li; Xiao Sun
Journal:  BMC Genomics       Date:  2022-10-20       Impact factor: 4.547

3.  Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping.

Authors:  Xinjian Yu; Yongjing Liu; Ming Chen
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

4.  A novel classification method for NSCLC based on the background interaction network and the edge-perturbation matrix.

Authors:  Yuan Tian; Caiqing Zhang; Wanru Ma; Alan Huang; Mei Tian; Junyan Zhao; Qi Dang; Yuping Sun
Journal:  Aging (Albany NY)       Date:  2022-04-09       Impact factor: 5.955

5.  HSSG: Identification of Cancer Subtypes Based on Heterogeneity Score of A Single Gene.

Authors:  Shanchen Pang; Wenhao Wu; Yuanyuan Zhang; Shudong Wang; Muyuan Niu; Kuijie Zhang; Wenjing Yin
Journal:  Cells       Date:  2022-08-08       Impact factor: 7.666

6.  Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network.

Authors:  Jianglin Zheng; Yue Qiu; Zhipeng Wu; Xuan Wang; Xiaobing Jiang
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.